Frank Takkinen
Stock Analyst at Lake Street
(2.07)
# 1,569
Out of 4,667 analysts
43
Total ratings
38.89%
Success rate
-4.08%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $12 → $15 | $13.52 | +10.95% | 6 | Oct 30, 2024 | |
| NOTV Inotiv | Upgrades: Buy | $2 → $4 | $3.21 | +24.61% | 6 | Sep 30, 2024 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $11 → $15 | $10.96 | +36.86% | 3 | Aug 27, 2024 | |
| SGHT Sight Sciences | Initiates: Buy | $10 | $3.73 | +168.10% | 1 | Aug 21, 2024 | |
| CLBT Cellebrite DI | Maintains: Buy | $14 → $17 | $19.00 | -10.53% | 2 | Aug 16, 2024 | |
| TELA TELA Bio | Maintains: Buy | $14 → $8 | $2.90 | +175.86% | 2 | Aug 13, 2024 | |
| AORT Artivion | Maintains: Buy | $28 → $30 | $27.17 | +10.42% | 2 | Jul 2, 2024 | |
| ELUT Elutia | Maintains: Buy | $5 → $10 | $4.38 | +128.31% | 2 | Jun 21, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $12 | $6.20 | +93.55% | 1 | Jun 4, 2024 | |
| COCH Envoy Medical | Maintains: Buy | $3 → $6 | $2.15 | +179.07% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.03 | +97.04% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $9.19 | +30.58% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $3.65 | +9.59% | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $305 → $350 | $184.77 | +89.42% | 1 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $5 | $1.55 | +223.62% | 3 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $1.40 | +542.86% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $2.45 | +553.06% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $1.03 | +796.12% | 2 | Jan 18, 2023 |
CVRx, Inc.
Oct 30, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $13.52
Upside: +10.95%
Inotiv
Sep 30, 2024
Upgrades: Buy
Price Target: $2 → $4
Current: $3.21
Upside: +24.61%
ClearPoint Neuro
Aug 27, 2024
Maintains: Buy
Price Target: $11 → $15
Current: $10.96
Upside: +36.86%
Sight Sciences
Aug 21, 2024
Initiates: Buy
Price Target: $10
Current: $3.73
Upside: +168.10%
Cellebrite DI
Aug 16, 2024
Maintains: Buy
Price Target: $14 → $17
Current: $19.00
Upside: -10.53%
TELA Bio
Aug 13, 2024
Maintains: Buy
Price Target: $14 → $8
Current: $2.90
Upside: +175.86%
Artivion
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $27.17
Upside: +10.42%
Elutia
Jun 21, 2024
Maintains: Buy
Price Target: $5 → $10
Current: $4.38
Upside: +128.31%
Pulmonx
Jun 4, 2024
Initiates: Buy
Price Target: $12
Current: $6.20
Upside: +93.55%
Envoy Medical
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $2.15
Upside: +179.07%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.03
Upside: +97.04%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $9.19
Upside: +30.58%
Sep 7, 2023
Initiates: Buy
Price Target: $4
Current: $3.65
Upside: +9.59%
Aug 2, 2023
Maintains: Buy
Price Target: $305 → $350
Current: $184.77
Upside: +89.42%
Jul 19, 2023
Maintains: Buy
Price Target: $2.5 → $5
Current: $1.55
Upside: +223.62%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $1.40
Upside: +542.86%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $2.45
Upside: +553.06%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $1.03
Upside: +796.12%